Nerve Blocks App
Anesthesia Assistant App
US Pain Management App
Pain Medicine Assistant App
POCUS App
IV Access App
MSK Knee App
VetRA App
Nerve Block Manual
Regional Anesthesia Updates
Anesthesiology Manual
Anesthesiology Review
Anesthesia Updates 2025
Anesthesia Updates 2026
Pediatric Anesthesia Updates
Airway Management Updates
US Interventional Pain Manual
Pain Medicine Updates
Mastering Difficult IV Access
PACU Nursing Manual
RA Veterinary Manual
Books
About
Learning objectives
- Describe Wegener’s granulomatosis
- Recognize the symptoms and signs of Wegener’s granulomatosis
- Anesthetic management of a patient with Wegener’s granulomatosis
Definition and mechanisms
- Wegener’s granulomatosis (WG) is a chronic, immunologic, systemic disease, characterized by a triad of necrotizing granulomas in the upper and lower respiratory tract, small- and medium-sized vessel vasculitis, and glomerulonephritis
- Involvement of the upper respiratory tract (i.e., nose and sinuses) is seen in nearly all WG patients
- Early diagnosis and treatment might lead to a full recovery
- Without treatment, the condition can be fatal
Signs and symptoms
Signs and symptoms develop suddenly or over several months
- Pus-like drainage with crusts from your nose, stuffiness, sinus infections, and nosebleeds
- Coughing, sometimes with bloody phlegm
- Shortness of breath or wheezing
- Fever
- Fatigue
- Joint pain
- Numbness in the limbs, fingers, or toes
- Weight loss
- Blood in urine
- Skin sores, bruising, or rashes
- Eye redness, burning or pain, and vision problems
- Ear inflammation and hearing problems
Complications
- Hearing loss
- Skin scarring
- Chronic kidney disease
- A loss of height in the bridge of the nose (saddling) caused by weakened cartilage
- Deep vein thrombosis
Treatment
Combination of corticosteroids and cytotoxic agents to induce and maintain remission
| Severe disease | Induce remission with immunosuppressants (e.g., rituximab or cyclophosphamide) in combination with high-dose corticosteroids (e.g., prednisone) Plasmapheresis if kidneys are involved Steroid dose is tapered slowly after remission → focus shifts to maintain remission state and prevent subsequent WG flares → less toxic immunosuppressants (e.g., rituximab, methotrexate, azathioprine, leflunomide, or mycophenolate) |
| Limited disease | Combination of methotrexate and corticosteroids Steroid dose is reduced after remission and methotrexate is continued as maintenance therapy |
Management
Suggested reading
- Sharma J, Lal J, Gehlaut P, Amanpreet, Dhawan G, Yadav A. Wegener’s Granulomatosis and Anaesthetic Implications: A Case Report. Int J Med Res Prof. 2018; 4(1): 479-81.
- Frost EAM. Wegener’s Granulomatosis, PHACE Syndrome: Rarities With Anesthetic Implications. December 20, 2018. Accessed January 26, 2023. https://anesthesiaexperts.com/uncategorized/wegeners-granulomatosis-phace-syndrome-rarities-anesthetic-implications/.
